Henry Linsert
Plus aucun poste en cours
Profil
Mr. Henry Linsert, Jr., was Independent Director at BioAmber, Inc. He is on the Board of Directors at BioAmber, Inc.
Mr. Linsert was previously employed as Chairman by Martek Biosciences Corp.
and President & Chief Executive Officer by Suburban Capital Corp.
He also served on the board at BioExx Specialty Proteins Ltd.
and TrioMed Innovations Corp.
He received his undergraduate degree from Duke University and a graduate degree from George Washington University.
Anciens postes connus de Henry Linsert
| Sociétés | Poste | Fin |
|---|---|---|
Martek Biosciences Corp.
 Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Directeur Général | 30/06/2006 |
| BIOAMBER INC. | Directeur/Membre du Conseil | 22/02/2016 |
| BIOEXX SPECIALTY PROTEINS LTD. | Directeur/Membre du Conseil | 03/10/2011 |
| Suburban Capital Corp. | President | 01/01/1987 |
TrioMed Innovations Corp.
 TrioMed Innovations Corp. Chemicals: Major DiversifiedProcess Industries TrioMed Innovations Corp. is a company dedicated to developing novel, antimicrobial technologies and products that help prevent the spread of infections and disease. Successor to Triosyn Corp. which was founded in 1992, the company has developed the 'TrioMed Technologies' creating innovative products such as the wound dressing incorporating unique antimicrobial properties and the next-generation in respirator and surgical facemask: the SafeLife B100 N95 Respirator (NIOSH-certified and U.S FDA-cleared). With more than 100 patents and patents pending, the scientific team and engineering groups have successfully harnessed the power of an iodinated resin novel molecular structure providing a non-toxic and more powerful antimicrobial efficacy based on the use of Tri-iodide. TrioMed has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in Vermont U.S.A, the company includes manufacturing facilities and technological centers in both Vermont and Mirabel QC, Canada. | Président | 22/11/2013 |
Formation de Henry Linsert
| George Washington University | Graduate Degree |
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Martek Biosciences Corp.
Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Health Technology |
| Suburban Capital Corp. | |
BioExx Specialty Proteins Ltd.
 BioExx Specialty Proteins Ltd. BiotechnologyHealth Technology BioExx Specialty Proteins Ltd. engages in the extraction of active ingredients from organic biomasses and inorganic feedstock. It focuses on the extraction of oil and proteins from oilseeds through the use of novel technologies. The company was founded by Christopher Douglas Carl in 2003 and is headquartered in Toronto, Canada. | Health Technology |
TrioMed Innovations Corp.
TrioMed Innovations Corp. Chemicals: Major DiversifiedProcess Industries TrioMed Innovations Corp. is a company dedicated to developing novel, antimicrobial technologies and products that help prevent the spread of infections and disease. Successor to Triosyn Corp. which was founded in 1992, the company has developed the 'TrioMed Technologies' creating innovative products such as the wound dressing incorporating unique antimicrobial properties and the next-generation in respirator and surgical facemask: the SafeLife B100 N95 Respirator (NIOSH-certified and U.S FDA-cleared). With more than 100 patents and patents pending, the scientific team and engineering groups have successfully harnessed the power of an iodinated resin novel molecular structure providing a non-toxic and more powerful antimicrobial efficacy based on the use of Tri-iodide. TrioMed has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in Vermont U.S.A, the company includes manufacturing facilities and technological centers in both Vermont and Mirabel QC, Canada. | Process Industries |
BioAmber, Inc.
 BioAmber, Inc. Chemicals: SpecialtyProcess Industries BioAmber, Inc. is an industrial biotechnology company, which produces sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in everyday products, including plastics, resins, paints, food additives and personal care products. The firm's products include bio-based succinic acid, butanediol and bio-based disodium succinate. The company was founded on October 15, 2008 and is headquartered in Montreal, Canada. | Process Industries |